Pharma 2020 Seminar -From vision to decision-

Pharma 2020 Seminar
-From vision to decisionDear Sir/Madam,
We are pleased to announce our upcoming seminar “Pharma2020 – From vision to decision”
which will be held in Tokyo and Osaka. The main speaker will be Dr. Steve Arlington who is the
worldwide leader of our Pharmaceuticals & Life Sciences Advisory Team. He will speak about
the decisions pharmaceutical companies will need to make between now and the end of the
decade in order to capitalize on the opportunities which will likely be presented after 2020.
The subject matter has been published globally in a report titled “Pharma2020 – From vision to
decision,” and has been well received.
We hope this seminar will be useful in making your decisions to increase the global
competitiveness of your business.
PwC Pharmaceuticals & Life Sciences
Overview
■Date & Time: April 25th, 2013
15:00 - 17:40 (Open 14:30 )
■Venue:
PricewaterhouseCoopers K.K. Tokyo Office, 22nd floor, Room F
Sumitomo Fudosan Shiodome Hamarikyu Bldg. 8-21-1 Ginza, Chuo-ku, Tokyo
■Event host:
PricewaterhouseCoopers K.K.
PricewaterhouseCoopers PRTM Management Consultants Japan LLC
■Intended audience:
Corporate Planning, R&D, Marketing or Regulatory Affairs functions of
pharmaceutical companies or companies planning entry into pharmaceuticals
■Capacity:
80 (Tokyo)
■Admission:
Free
■Topics:
See reverse side
■Language:
English and Japanese (Interpretation will be available)
■Application:
Access the following URL
http://www.pwc.com/jp/seminar5
■Q&A contact: Pharma2020 seminar office, Motoda/Enjoji
E-mail : [email protected]
〒104-0061
Sumitomo Fudosan Shiodome Hamarikyu Bldg. 8-21-1 Ginza, Chuo-ku, Tokyo
■Privacy policy:
PwC will handle all privacy information under the PwC privacy policy .
Details (http://www.pricewaterhousecoopers.co.jp/privacy/index.html)
PwC Pharma 2020 Seminar –From vision to decision
＜Contents＞
＜Time＞
＜Speakers＞
14:30-15:00
Registration
15:00-15:30
Opening remarks
Pharma2020: Introduction to Key Topics
PricewaterhouseCoopers K.K.
Pharmaceuticals and Life Sciences
Partner Eimei Shu
15:30-16:30
Pharma2020: From vision to decision
PricewaterhouseCoopers LLP (UK)
Pharmaceuticals and Life Science
Advisory leader Steve Arlington
16:30-16:40
Break
16:40-17:20
Pharma2020: Recommendations for future initiatives
17:20-17:35
Q&A
17:35-17:40
Closing remarks
PricewaterhouseCoopers K.K.
Pharmaceuticals and Life Sciences
Partner Shinya Yamamoto
17:40-
Reception
Available for private consultation/exchange opinions
PricewaterhouseCoopers
PRTM Management Consultants Japan LLC
Partner Yorozu Tabata
Speaker
Steve has considerable experience in consulting to the healthcare industry on a wide
range of issues such as strategy, new product/business development, manufacturing
and regulatory. Steve also has over seventeen years of management experience in
pharmaceuticals, diagnostics and medical devices R&D. He took part in the
development and launch of world class drugs and diagnostic tests.
Within PwC, Steve leads the Global Pharmaceuticals and Life Sciences Advisory Team
where he works extensively with senior management, leading multi-national programs.
He lead the recently released thought leadership report Pharma 2020. Previously, he
authored the highly acclaimed “Pharma 2005: An Industrial Revolution in R&D”,
“Pharma 2005: The Race to e-R&D”, “Pharma 2005: Marketing to the Individual” and
“Pharma 2010: The Threshold of Innovation”.
PwC U.K.
Partner
Steve Arlington
Steve is a visiting professor at University College London, Department of Biochemical
Engineering and is a member of the Royal Society of Medicine, the Drug Information
Association (DIA). He teaches at FDA, SFDA and EMA Drug Development Programs.
He holds a PhD in Immunopharmacology from the University of Birmingham.
Access
• JR: Shimbashi Station, A3 Exit (8 minutes by walk)
• Subway: Ginza Line, Shimbashi Station, A3 Exit (8 minutes by
•
•
•
•
walk)
Subway: Asakusa Line, Shimbashi Station A4 Exit (7 minutes by
walk)
Subway: Oedo Line, Shiodome Station (5 minutes by walk)
Yurikamome Line, Shiodome Station (5 minutes by walk)
Subway: Hibiya Line, Asakusa Line, Higashi Ginza Station,
Nankai Bldg., Exit (9 minutes by walk)
© 2013 PricewaterhouseCoopers Co., Ltd. All rights reserved. PwC refers to the PwC network member firms in Japan and/or their specified subsidiaries, and may sometimes refer to
the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.